ASPIRE BIOPHARMA HOLDINGS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-238.6K | $-238.6K | — | — |
| FY2022 | $-1.4M | $-1.4M | — | — |
| FY2023 | $-653.1K | $-653.1K | — | — |
| FY2024 | $-265.2K | $-265.2K | — | — |
| FY2025 | $-4.9M | $-4.9M | — | $14.1M |